Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?
- 1 October 1993
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 7 (5) , 501-507
- https://doi.org/10.1111/j.1365-2036.1993.tb00125.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Clinical and Economic Factors in the Selection of Drugs for Gastroesophageal Reflux DiseasePharmacoEconomics, 1993
- Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter studyGastroenterology, 1992
- OmeprazoleDigestive Diseases and Sciences, 1991
- Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with RanitidineScandinavian Journal of Gastroenterology, 1991
- Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.Gut, 1990
- Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.Gut, 1990